Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Richardson P et al. – The adverse sequalae of inadequate pain control in the burn population have been long recognised, yet control of pain remains inadequate globally. The family of opioid analgesics provide the backbone of analgesia to burn patients. NMDA receptor antagonist such as ketamine and gabapentin are increasingly recognised as useful adjuncts, capable of marked opiate sparing effects in this population. The simple analgesic paracetamol has both anti–pyretic and opioid–sparing properties and justly deserves its place in the pharmacological treatment of every burn patient.

Today in Pain Management...keeping you current

Adverse event profile of tramadol in recent clinical studies of chronic osteoarthritis pain
Current Medical Research and Opinion, 12/07/09

Simulated acupuncture and real acupuncture both reduced low back pain dysfunction and symptoms
Evidence-Based Medicine, 12/07/09

Intraspinal techniques for pain management in cancer patients: a systematic review
Supportive Care in Cancer, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address